TCTMD
banner
tctmd.bsky.social
TCTMD
@tctmd.bsky.social
Your source for breaking news, topical videos, and slides covering cardiovascular disease and interventions. Register at http://tctmd.com
HRS/ACC Give Advice on Ablations in Ambulatory Surgical Centers
HRS/ACC Give Advice on Ablations in Ambulatory Surgical Centers
HRS/ACC Give Advice on Ablations in Ambulatory Surgical Centers [email protected] Tue, 11/25/2025 - 15:44 Todd Neale The timing of the new statement is fortuitous, as CMS cleared the way for ablation reimbursement in ASCs just last week.
www.tctmd.com
November 25, 2025 at 8:51 PM
The use of the Farapulse system reduced recurrent atrial arrhythmias, improved quality of life, and eased psychological distress compared with a sham procedure in patients with paroxysmal or persistent AF, according to results from the small PFA-SHAM trial. #AHA2025 www.tctmd.com/news/sham-co...
Sham-Controlled Trial, and More, Bolster Pulsed-Field Ablation for AF
The PFA-SHAM trial and MANIFEST-US registry support the efficacy and safety of the increasingly used ablation modality.
www.tctmd.com
November 25, 2025 at 2:12 PM
EchoPrime, an AI-based model, seems to increase workflow efficiency and provide a more comprehensive interpretation of echocardiograms after being trained on more than 12 million videos and paired text reports. www.tctmd.com/news/largest...
Largest AI-Echo Model Shows Promise for Increasing Workflow Efficiency
EchoPrime was trained on more than 12 million videos; it’s now being tested clinically, with more data expected next year.
www.tctmd.com
November 24, 2025 at 9:02 PM
In the latest On Record, Caitlin E. Cox and Kenneth Rosenfield discuss the roadblocks and solutions to lack of access in the management of pulmonary embolism during #TCT2025. Watch it now: www.tctmd.com/videos/on-re...
November 24, 2025 at 7:24 PM
Asundexian Reduces Recurrent Stroke Without Bleeding Risk: OCEANIC-STROKE
Asundexian Reduces Recurrent Stroke Without Bleeding Risk: OCEANIC-STROKE
Asundexian Reduces Recurrent Stroke Without Bleeding Risk: OCEANIC-STROKE [email protected] Mon, 11/24/2025 - 13:50 Michael O'Riordan The top-line results are good news for asundexian after disappointment in the AF setting.
www.tctmd.com
November 24, 2025 at 6:59 PM
Revascularization Decisions in the Elderly Require a Holistic Approach: AHA
Revascularization Decisions in the Elderly Require a Holistic Approach: AHA
Revascularization Decisions in the Elderly Require a Holistic Approach: AHA [email protected] Mon, 11/24/2025 - 11:15 Caitlin E. Cox Cardiology can learn lessons from geriatric medicine on how to look at the big picture and involve patients in the process.
www.tctmd.com
November 24, 2025 at 4:21 PM
Stress CMR may facilitate diagnosis for patients with angina but no obstructive coronary arteries (ANOCA), which can improve angina and health-related quality of life, according to data from the CorCMR trial presented at #AHA2025. www.tctmd.com/news/stress-...
Stress CMR Facilitates Diagnosis, Targeted Care in ANOCA: CorCMR
Quantifying blood flow instead of relying on angiography alone led to a change in diagnosis for 53% of patients.
www.tctmd.com
November 23, 2025 at 4:11 PM
For patients who have heart failure with reduced ejection fraction, a polypill containing a beta-blocker, a sodium-glucose cotransporter 2 inhibitor, and a mineralocorticoid receptor antagonist improves outcomes including LVEF, quality of life, and HF events. #AHA2025 www.tctmd.com/news/poly-hf...
POLY-HF: Polypill Pays Dividends in Patients With HFrEF
The combination therapy improved LVEF, quality of life, clinical outcomes, and more, but implementation questions remain.
www.tctmd.com
November 22, 2025 at 1:54 PM
Long-Awaited CREST-2 Results Bolster Stents for Asymptomatic Carotid Stenosis
Long-Awaited CREST-2 Results Bolster Stents for Asymptomatic Carotid Stenosis
Long-Awaited CREST-2 Results Bolster Stents for Asymptomatic Carotid Stenosis [email protected] Fri, 11/21/2025 - 16:51 Todd Neale Stenting, but not endarterectomy, significantly reduced stroke risk compared with intensive medical therapy alone.
www.tctmd.com
November 21, 2025 at 10:02 PM
Patients with severe hypertriglyceridemia saw a significant reduction in triglyceride levels by 6 months and a lower risk of acute pancreatitis when treated with olezarsen, based on results from two phase III randomized trials. #AHA2025 www.tctmd.com/news/olezars...
Olezarsen Cuts Triglycerides, Pancreatitis Risk in Severe Hypertriglyceridemia
There was an increase in the hepatic fat fraction, the long-term consequences of which are unknown, says Robert Rosenson.
www.tctmd.com
November 21, 2025 at 4:46 PM
On this episode of Heart Valve Matters, Ami Bhatt and Tim Ryan talk about heart valve technology and the development of the Melody valve. Listen now: www.tctmd.com/audio/pediat...
November 21, 2025 at 3:43 PM
Dig Deeper When Dealing With Nonobstructive CAD, AHA Urges
Dig Deeper When Dealing With Nonobstructive CAD, AHA Urges
Dig Deeper When Dealing With Nonobstructive CAD, AHA Urges [email protected] Fri, 11/21/2025 - 10:05 Caitlin E. Cox A scientific statement reviews data in this heterogeneous category and proposes a risk-based staging system.
www.tctmd.com
November 21, 2025 at 3:17 PM
Listen to the latest Heart Valve Matters, where Ami Bhatt, Jenny Zablah, and Gareth Morgan discuss new advanced imaging tools for treating congenital heart disease. www.tctmd.com/audio/pediat...
November 20, 2025 at 8:59 PM
High Adolescent BP Tied to Subclinical Disease in Middle Age
High Adolescent BP Tied to Subclinical Disease in Middle Age
High Adolescent BP Tied to Subclinical Disease in Middle Age [email protected] Thu, 11/20/2025 - 15:46 Michael O'Riordan Checking blood pressure in the young prevents long-term consequences that can lead to CVD, say researchers.
www.tctmd.com
November 20, 2025 at 8:55 PM
Pediatric and Congenital Heart Disease Series: The Medtronic Melody TPV Experience
Pediatric and Congenital Heart Disease Series: The Medtronic Melody TPV Experience
Pediatric and Congenital Heart Disease Series: The Medtronic Melody TPV Experience [email protected] Thu, 11/20/2025 - 14:21 3 minutes 41 seconds ago Ami Bhatt speaks with Tim Ryan about heart valve technology and the development of the Melody valve.
www.tctmd.com
November 20, 2025 at 7:25 PM
Prasugrel may be better, compared with ticagrelor, for DAPT following PCI in patients with diabetes and multivessel coronary disease, based on data from the TUXEDO-2 trial presented at #AHA2025. Read more here: www.tctmd.com/news/prasugr...
Prasugrel May Be Better Than Ticagrelor After PCI for Diabetes Patients With MVD
In TUXEDO-2, ticagrelor failed to meet the bar for noninferiority, with most outcomes hinting at an advantage for prasugrel.
www.tctmd.com
November 20, 2025 at 5:56 PM
Online Calculator Allows Young Adults to See How Their 30-Year CV Risk Compares to Peers’
Online Calculator Allows Young Adults to See How Their 30-Year CV Risk Compares to Peers’
Online Calculator Allows Young Adults to See How Their 30-Year CV Risk Compares to Peers’ [email protected] Wed, 11/19/2025 - 16:27 Yael L. Maxwell Some question if patients want this information, but others say this tool can put risk into context and prompt lifestyle changes.
www.tctmd.com
November 19, 2025 at 9:36 PM
On the latest Talking Points podcast, James Benenati, Robert Lookstein, and Rachel Rosovsky talk about the STORM-PE trial. Listen now: www.tctmd.com/audio/storm-...
November 19, 2025 at 5:25 PM
Auto-MACE, an AI-based model, has been found to successfully adjudicate major adverse events in clinical trials, including CV death and stroke, at rates comparable to expert physicians. Data suggests it can increase efficiency and reduce costs. #AHA2025 www.tctmd.com/news/artific...
Artificial Intelligence Successfully Adjudicates Clinical Events in CV Trials
The hope is using AI to judge outcomes will ease the high cost and complexity of running big clinical trials, say researchers.
www.tctmd.com
November 19, 2025 at 4:34 PM
Metformin Before Catheter Ablation for AF Helps Nondiabetic Patients With Overweight
Metformin Before Catheter Ablation for AF Helps Nondiabetic Patients With Overweight
Metformin Before Catheter Ablation for AF Helps Nondiabetic Patients With Overweight [email protected] Tue, 11/18/2025 - 15:55 Caitlin E. Cox The META-AF trial found fewer recurrences of atrial arrhythmias, a benefit unexplained by weight loss or glycemic control.
www.tctmd.com
November 18, 2025 at 9:04 PM